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Abstract
Objectives Desmoplastic small round cell tumours (DSRCTs)
are rare aggressive tumours of young adults that present late
and have poor prognosis. This review discusses distinctive
radiological features, histopathology and clinical course of
this soft-tissue sarcoma.
Methods From 1991 to 2012, the radiology of 20 patients
with pathologically proven DSRCT was independently
reviewed by two experienced radiologists. The clinical pre-
sentation, treatment and outcome were recorded.
Results Patients: 16 men, four women; mean age 28.3 years.
Computed tomography (CT) demonstrated peritoneal/omental
masses without an organ of origin (94 %), with the majority of
cases demonstrating large (>5 cm) dominant soft-tissue de-
posit (80 %) with multiple smaller foci. CT and magnetic
resonance imaging (MRI) typically demonstrated heteroge-
neous soft-tissue enhancement with cystic degeneration. A
minority (20 %) demonstrated calcification. Lymph node en-
largement occurred in 50 % of cases. Distant metastatic
disease occurred in 25 %. Painful abdominal masses were
clinically predominant. Treatment strategies include combina-
tion chemotherapy with debulking surgery and/or radiothera-
py. Median survival from diagnosis was 22.8 months.
Conclusion Features of multifocal peritoneal/omental masses,
usually in combination with a dominant soft tissue deposit, are
distinctive in this rare sarcoma. CT/MRI defines the extent of
disease and characterises supporting imaging findings. Prolific
desmoplastic reaction histologically separates DSRCT from
similar subtypes. Combination treatment strategies can infer a
survival benefit but prognosis remains poor.
Teaching Points
• DSRCTs are rare tumours of young adults (mean age
28.3 years) with a male predominance (4:1).
• Painful abdominal masses clinically predominate. Non-
specific features of malignancy can be present.
• Multifocal peritoneal masses with a dominant soft tissue
lesion is a distinctive imaging finding.
• A large desmoplastic reaction differentiates DSRCTs from
histologically similar round cell subtypes.
• Despite debulking surgery with adjuvant chemotherapy,
median survival from diagnosis is 22.3 months.
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Introduction
Desmoplastic small round cell tumour (DSRCT) is a rare but
highly aggressive soft tissue sarcoma that arises most com-
monly in the abdomino-pelvic cavity of males in adolescence
or young adulthood [1]. First reported in 1989 by Gerald et al.
[1] and Ordonez et al. [2], this tumour is so called due to its
typical histological finding of nests of small blue round cells
within a dense desmoplastic stroma.
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Differentiation of DSRCT from other soft tissue sar-
comas is important, as it is a high-grade neoplasm often
presenting with advanced disease, with a mean survival
time of less than 3 years [3, 4]. Five-year survival is
less than 15 %.
There are limited data describing the imaging features of
DSRCT with several published case reports but no substan-
tial case series.
This is the largest imaging review of DSRCT to date in the
context of the demographic and clinical data, describing the
imaging features on computed tomography (CT), magnetic
resonance imaging (MRI), ultrasound and positron emission
tomography (PET) that are most suggestive of DSRCT. The
role of imaging, current treatment options and the follow-up of
these patients is also discussed.
Methods
The imaging of 28 patients with biopsy-proven DSRCT was
referred to the Royal Marsden Hospital Soft Tissue Tumour
Unit for diagnosis and management over a 21-year period
(from 1st January 1991 to 21st May 2012). Eight patients
were referred for opinion only and were managed subsequent-
ly at their local hospital. The referral imaging was not PACS-
archived for recall analysis at our institution and these patients
were excluded from the study (n=20).
The initial imaging of the majority of patients was per-
formed at local hospitals where imaging protocols adopted
in those studies could not be influenced. Imaging was only
repeated if clinically indicated. In all patients, the diagnosis
of DSRCT was confirmed at our institution, following per-
cutaneous or surgical biopsy using a combination of histo-
logical, immunohistochemical and molecular cytogenetic
profiles. The majority of these biopsies were performed in
this hospital and the few performed at the referring institu-
tion had the biopsy samples re-reviewed by a specialist soft
tissue tumour pathologist. All subsequent clinical manage-
ment was also undertaken in this institution.
Clinical and demographic data (including clinical man-
agement and patient outcome) was obtained from the data-
base and review of individual patient case notes was
undertaken where appropriate. Progression-free and overall
survival was estimated using the Kaplan Meier method. All
external imaging was retrieved and reviewed.
Two radiologists experienced in sarcoma imaging
reviewed all imaging studies and consensus opinion was
reached. In each study, the following imaging findings were
recorded: the presence of peritoneal deposits; a dominant
soft tissue lesion (location, size, the presence of cystic,
heterogeneous or calcific components and the presence of
enhancement); peritoneal or peritoneal fluid; site and loca-
tion of enlarged lymph nodes; visceral obstruction; distant
metastatic disease. Enhancement of the lesion was charac-
terised by comparing the density of the lesion with that of
the normally enhancing liver.
Results
There were 16 male and four female patients (ratio 4:1).
The mean age at presentation was 28.3 years (age range
15–46 years).
Clinical features
The most common clinical presentation was of an abdomi-
nal mass (15 patients [75 %]). The next most common
presentations were with abdominal pain (ten patients
[50 %]) and weight loss (three patients [15 %]), with sweats
(one patient [5 %]), back pain (one patient [5 %]) and
lethargy (one patient [5 %]) also noted. In two patients
(10 %), the presentation was an incidental finding at surgery,
in one patient during appendicectomy for appendicitis and
in the other during caesarean section delivery.
CT findings
All patients underwent contrast enhanced CT (CECT) at pre-
sentation, prior to treatment. Of these, six underwent CT of the
abdomen and pelvis and 14 underwent CT of the chest, abdo-
men and pelvis. CECT of the chest was obtained in the arterial
phase, and CECT of the abdomen and pelvis was obtained in
the portal venous phase. Of the six patients who did not have
CT imaging of the chest, chest radiographs were performed.
The most common CT finding at presentation was peri-
toneal/omental disease (19/20 patients [95 %]). In 17 of
these 19 patients (89 %), this manifested as multiple perito-
neal/omental soft tissue masses, with a solitary peritoneal
mass seen in the remaining 2/19 (10 %) cases (Fig. 1, 2, 3
and 4). In the one case without peritoneal disease, there was
a right paravertebral mass posterior to the diaphragmatic
crus with metastatic involvement of the adjacent T11 and
T12 vertebral bodies (Fig. 5).
A dominant soft tissue lesion was seen in 16/20 cases
(80 %). In the context of multiple peritoneal/omental soft
tissue deposits (Fig. 2), this was defined as being at least
double the size of the next largest soft tissue deposit. Of
these dominant lesions, 10/16 (63 %) had their epicentre in
the abdomen, 5/16 (31 %) in the pelvis and 1/16 (6 %) in a
paravertebral location posterior to the right diaphragmatic
crus. In all 16 cases with a dominant soft tissue lesion, the
size of the lesion was ≥ 5 cm and in 11/16 cases (69 %) its
size was ≥ 10 cm.
Enhancement of the soft tissue lesions following intrave-
nous contrast was demonstrated in all cases. The lesions
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were heterogeneous in 14/20 patients (70 %) and demon-
strated low attenuation cystic areas in 11/20 patients (55 %,
Fig. 1a). Calcification was seen within the soft tissue lesions
in 4/20 cases (20 %, Fig. 2).
Peritoneal free fluid was seen in 6/20 patients (30 %)
with this fluid being large volume in nature in 2/6 (33 %) of
Fig. 1 a Axial CECTof the abdomen in a 24-year-old manwith DSRCT.
There is a large, heterogeneous peritoneal mass in the abdominal cavity
(white arrowheads). It is predominantly cystic but has solid enhancing
tissue within it (black arrows). Peritoneal thickening and a peritoneal soft
tissue nodule are seen separate to the mass (white arrow). b Axial CECT
of the abdomen in a 24-year-old man with DSRCT. There are multiple
mesenteric and peritoneal soft tissue nodules (white arrows). There is
diffuse peritoneal thickening scalloping the edges of the liver (black
arrowheads)
Fig. 2 Axial CECT of the abdomen in a 25-year-old man with DSRCT.
There is a large heterogeneous, mixed solid and cystic mass in the left
upper quadrant (white arrowheads). The soft tissue component enhances.
There is calcification within it (black arrow)
Fig. 3 Axial CECT of the abdomen and pelvis in a 23-year-old male
patient with DSRCT. There is diffuse omental thickening (white arrows)
as well as moderate volume of ascites (black arrow)
Fig. 4 a Axial CECT of the abdomen in a 22-year-old female patient
with DSRCT. There are multiple hypo-attenuating, heterogeneous liver
metastases (black arrows). There is diffuse peritoneal thickening scal-
loping the liver edges (white arrowheads). There is small volume
ascites (white arrow). b Axial CECT of the pelvis in a 22-year-old
woman with DSRCT. There are multiple peritoneal soft tissue nodules
in the pelvis (white arrows)
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these cases (Fig. 3). Pleural effusions were noted in 5/20
cases (25 %).
Lymph node enlargement was demonstrated in 10/20
patients (50 %) with sites of enlargement in the abdomen in
8/10 (80 %) cases, of these 8/8 (100 %) in a para-aortic, 6/
8 (71 %) aorto-caval, 4/8 (50 %) porto-caval and 1/8 (13 %) in
a mesenteric location. Mediastinal lymph node enlargement
was seen in two of the ten cases (20 %).
Metastases were noted in the liver in 4/20 patients (20 %,
Fig. 4a), in the lung (as a solitary lesion) in 1/20 patients
(5 %) and in the bones in 1/20 patients (5 %).
In one patient (6 %), a dominant soft tissue mass in the
region of the lesser omentum resulted in biliary obstruction,
requiring treatment with a biliary stent.
MRI findings
In addition to CT, five patients underwent MRI, with three
having MRI of the abdomen and pelvis, one of the thoraco-
lumbar spine and one of the lumbar spine. MRI was per-
formed as clinically indicated to further characterise dominant
lesions or findings on the CT studies. In all MRI studies, fat-
saturated T1 weighted sequences were performed pre- and
post-intravenous gadolinium to assess enhancement.
In the three MRIs performed to further characterise dom-
inant soft tissue lesions, the dominant lesion was heteroge-
neous but predominantly hypo- or iso-intense to skeletal
muscle on T1-weighted sequences and hyperintense on
T2-weighted sequences (Fig. 6). Enhancement was heterog-
enous following contrast (Fig. 7).
The MRI of the lumbar spine confirmed a low-signal
lesion within the L2 vertebral body on the T1-weighted
images (Fig. 5), consistent with a metastasis (which was
suspected on CT).
Treatment and outcome
Sixteen patients were treated with first-line combination
chemotherapy between 1998 and 2009. Of these sixteen,
three were treated elsewhere.
Of the 13 patients treated with first-line chemotherapy
(with follow-up) at The Royal Marsden Hospital, 6/13
(46 %) achieved a partial response and 5/13 (39 %) stable
disease. Two (15 %) patients progressed on first-line chemo-
therapy. Of these 13 patients, two received multimodality
management consisting of chemotherapy, surgery and radio-
therapy and were alive, 18 and 27 months respectively fol-
lowing initiation of therapy (one having developed severe
malabsorption post-therapy). One patient was treated with
chemotherapy and surgery, and was alive 110 months follow-
ing commencement of treatment. One patient was treated with
chemotherapy and radiotherapy, and died 50 months follow-
ing diagnosis. All the other patients (n=9) received combina-
tion chemotherapy alone and have died of disease (69 %).
The median progression-free survival from starting first
line chemotherapy was 15.6 months (95 % CI 8.2–23.1).
The median overall survival from diagnosis was 22.8 months
(95 % CI 10–35.5).
Fig. 5 Sagittal T1-weighted MRI of the lower thoracic spine in a 20-
year-old man with DSRCT. There is a heterogeneous paravertebral mass
lying anterior to the T11 and T12 vertebral bodies (white arrowheads).
Whilst there is no direct invasion of the vertebral bodies, there is low
signal intensity within the T11 and T12 vertebral bodies in keeping with
bony metastatic disease (white arrows)
Fig. 6 Coronal T2-weighted MRI of the abdomen in a 21-year-old
man with DSRCT. There is a complex lesion in the gallbladder fossa,
which demonstrates a measurable soft tissue component with a periph-
eral myxoid degeneration. There is no direct invasion into the adjacent
right lobe of liver. The soft tissue returns signal that is marginally
higher than the adjacent hepatic parenchyma and isointense to the
spleen, with characteristic T2 fluid signal returned from the cystic
component
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Discussion
DSRCT is an extremely rare and aggressive soft tissue
sarcoma, with only a few hundred cases reported in the
literature. This tumour generally presents with multifocal
abdomino-pelvic masses and is reported to occur in adoles-
cence and early adulthood. In our series of patients, the
mean age at presentation was 28.3 years, with the oldest
patient being 46 years of age. This is slightly higher than the
usual age range of 18–25 years, although DSRCT has been
reported in patients older than this [5]. The male-to-female
ratio of DSRCT is reported to be 4:1 [6, 7]. In our patient
cohort, the male-to-female ratio was 5:1, confirming a male
preponderance in this histological subtype.
The aetiology of DSRCT is unknown but it is thought to
be a malignancy of the mesothelium and, as such, occurs
most commonly in the peritoneum and omentum [8]. It has
also been noted to occur in other sites of mesothelial origin
such as the pleura and tunica vaginalis of the testis as well as
solid organs including the pancreas, liver, kidneys and ova-
ries [5, 9–12]. In our series, 19 cases (95 %) involved the
peritoneum or omentum, with only one case occurring in an
extraperitoneal location (Fig. 5).
The imaging findings in our series represent the largest
review in the literature to our knowledge. Characteristic
imaging features included diffuse peritoneal/omental masses
(95 %) with multiple soft tissue deposits seen in 79 % of
these cases (Fig. 4b). A dominant soft tissue mass not
involving a visceral organ of origin, either solitary or at
least twice the size of other peritoneal/omental lesions was
seen in 80 % of patients (Figs. 1a, 2). This has been noted in
previous smaller studies [13–16]. In a review of the CT
findings of 11 patients with DSRCT by Bellah et al. [14],
in their cohort 82 % of the dominant lesions were in the
rectovesical or rectouterine space and they postulated that
this might be due to the dynamic flow of peritoneal fluid and
the dependency of these locations. However, our findings do
not support this theory, with only 36 % (5/16 patients) of the
dominant lesions occurring in the pelvis, the remainder
occurring in the abdomen (62 %) and the right paravertebral
region arising from the diaphragmatic crus (6 %).
Regarding the imaging characteristics of the soft tissue
lesions, enhancement following intravenous contrast was seen
in all cases on both CT and MRI. This was heterogeneous in
70 % of cases on CT and in 100 % of the four cases in which
lesions were characterised further using contrast enhanced
MRI. Central cystic morphology was seen within lesions on
CT in 50 % of cases and in 100 % of the four cases evaluated
on MRI, most likely to be due to necrosis, haemorrhage or a
fibromyxoid component to the tumour (Figs. 1a, 2) [14, 16].
These findings are consistent with previous smaller studies
[14–19, 21]. The presence of calcification within lesions has
been reported variably in the literature, with one study of 13
patients documenting the absence of lesional calcification in
all patients [13]. However, other smaller studies have shown a
prevalence of lesional calcification of between 22–55 % [14,
15, 19]. In our cohort, lesional calcification was noted in 20%
of cases on CT (Fig. 2). This suggests that whilst lesional
calcification is a not uncommon finding in DSRCT, it is not
frequent enough a finding to be characteristic. Whilst haemor-
rhagic tumour necrosis has been noted on MRI in the litera-
ture, none of the cases evaluated with MRI in our cohort
demonstrated lesional T1 hyperintensity or T2 fluid-fluid
levels to suggest the presence of haemorrhage [19, 20, 22].
Again, this does not appear to be a particularly characteristic
finding.
Lymph node enlargement was a common finding, dem-
onstrated in 50 % of patients at presentation. Of those
patients with lymph node involvement, 80 % had retroper-
itoneal lymph node enlargement, with the next most com-
mon sites being in the mediastinal (20 %) and mesenteric
(13 %) regions. This is consistent with prior smaller studies
noting lymphatic spread at presentation [14–19]. Ascites
(30 %) and pleural effusions (25 %) at presentation were
common findings in our study, and this is again consistent
with smaller studies.
Quaglia et al. [4] demonstrated distant metastases in 50 %
of their cases and whilst the frequency in our larger patient
cohort was lower (30 %), our findings still suggest that
metastases are common at presentation. As such, imaging
studies should be evaluated thoroughly for metastases, par-
ticularly in the liver and bones (Fig. 4a). Smaller cohort
studies of four to eight patients suggest pleural involvement
in 63–100 % [20, 21]. This contradicts our findings of only
one patient (0.5 %) having macroscopic disease above the
diaphragm.
In our experience, CT plays the most useful role in
diagnosis and staging of DSRCT and should be the initial
imaging test of choice. Ultrasound may be helpful in guid-
ing percutaneous biopsy of relatively superficial lesions but
it does not help characterise lesions further, typically
Fig. 7 Desmoplastic small round cell tumour. Histology shows
sheets of tumour composed of small round cells (white arrow)
which are surrounded by prominent sclerotic fibrous stroma (black arrow).
(Haematoxylin and eosin, ×100)
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demonstrating lobulated, heterogeneous hypo-echoic lesions
(Fig. 8) [14, 15]. Whilst MRI can provide some further char-
acterisation of the lesions of DSRCT (such as the presence of
intra lesional haemorrhagic necrosis), these characteristics do
not occur frequently enough with this tumour to make the
findings helpful in differentiating DSRCT from other tumours.
Fluorodeoxyglucose (FDG)-PET/CT has been shown to iden-
tify occult lesions not demonstrated on CT or MRI [15, 19].
Histologically because the small round cells are seen embed-
ded in a prominent desmoplastic stroma (Fig. 7) they demon-
strate lesional FDG activity (Fig. 9). This in particular may be
useful in the assessment of tumour response to chemo- or
radiotherapy [23], and could detect early tumoral relapse be-
fore conventional anatomical imaging [24–26].
Therapeutic options in the treatment of DSRCTs are
limited. Surgery is often extremely challenging and com-
plete resection is rarely achievable. Debulking surgery in
combination with chemotherapy has been attempted. A ret-
rospective series from Memorial Sloane Kettering Cancer
Centre reviewed 66 patients treated with debulking surgery,
multi-agent chemotherapy and abdominopelvic radiother-
apy. A survival benefit was demonstrated when com-
pared to patients who did not undergo debulking
surgery (58 % 3 year survival compared to 0 %, P<
0.00001) [27]. Local treatment to liver metastases following
surgery has also been reported with radiofrequency ablation,
cryotherapy and more recently Yttrium microsphere radio-
embolotherapy. [28]
Chemotherapy alone is associated with high toxicity and
poor overall survival benefit with evidence to suggest che-
motherapy is efficacious when used as part of multimodality
therapy. One such regimen, the P6 protocol comprises cy-
clophosphamide, doxorubicin, vincristine, ifosfamide and
etoposide [29]. The role of platinums, topoisomerase inhib-
itors and temozolomide has also evaluated but responses are
rarely durable. High-dose chemotherapy with autologous
stem cell rescue has been explored but no overall survival
benefit has been demonstrated.
Hyperthermic intra-peritoneal chemotherapy (HIPEC),
developed in the therapy of metastatic ovarian carcinoma,
has been investigated. A retrospective review compared
patients receiving chemotherapy alone, debulking surgery
alone and debulking surgery followed by HIPEC. There was
Fig. 8 Two trans abdominal
ultrasound images acquired in
the transverse and longitudinal
plane in a 29-year-old man with
DSRCT. They demonstrate a
heterogeneously echogenic
soft tissue mass within the left
lower quadrant that is
macroscopically inseparable
from the adjacent peritoneum
and bowel. There is associated
ascites
Fig. 9 Coronal 18F-FDG PET/CT imaging in a 21-year-old male patient
with DSRCT. This image demonstrates the extent of disease with
multiple areas of FDG uptake within the abdomen, which correspond to
peritoneal deposits and retroperitoneal lymph node disease on the CT
component. Imaging also confirms the presence of hepatic metastases
which were covert on a previous contrast enhanced CT scan
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no statistical difference between the two surgical groups,
reporting 62 % and 71 % 3-year survival respectively. The
cohort receiving surgery did significantly better than those in
the chemotherapy alone group (26 % 3-year survival) [30].
The role of novel molecularly targeted agents has pro-
voked interest as the translocation associated with DSCRT
could potentially give rise to therapeutic targets such as
insulin-like growth factor 1 and platelet-derived growth
factor. Case reports show benefit with novel agents such as
Imatinib, Sunitinib, Sorafenib and Temsirolimus. This area
is promising and deserves further exploration.
Whole abdominal radiotherapy (WAP) has been used as
part of multimodality treatment in addition to surgery and
chemotherapy. WAP is a toxic treatment in both the long and
short term, and note is made that in one series the majority
of patients relapsed in field. Intensity modulated radiation
therapy (IMRT) has been shown to be feasible and associ-
ated with less bowel toxicity [31].
DSCRT remains a challenging disease to treat and evidence
supports the use of maximum debulking therapy, where pos-
sible in combination with multiagent chemotherapy. There
remains a need for prospective clinical trials, although this is
challenge in such a rare tumour type.
Conclusion
The majority of patients with DSRCT present late and usually
with advanced disease. Our case series of 20 patients, support
smaller cohort studies in the characteristic imaging features
and the diagnosis should be suspected in adolescent/young
males in whom imaging studies demonstrate:
1. Diffuse peritoneal involvement with multiple soft tissue
lesions
2. Dominant soft tissue lesion measuring at least 5 cm
without a visceral organ of origin
Supporting ancillary findings include:
1. Heterogeneous tumoral enhancement
2. Cystic change and calcification
3. Metastatic spread to retroperitoneal lymph nodes, liver
and spine These imaging features were not found fre-
quently enough to be characteristic of DSRCT, and
although their incidence varies throughout the literature,
they are in line with smaller cohort groups. Several
studies found a strong propensity towards pleural dis-
ease, but despite our common findings of a pleural
effusion, our data did not support macroscopic pleural
involvement.
There is unanimous support for CT as the primary imag-
ing modality of choice in DSRCT, with ultrasound and MRI
offering additional information in individual cases. FDG-
PET/CT can infer a response to treatment and may prove
useful in tumour relapse.
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